Education
About Us
Working with TipRanks
Follow Us
QuiaPEG Pharmaceuticals Holding AB (SE:QUIA)
:QUIA
QUIA Stock Chart & Stats
kr0.01
<kr0.01(28.13%)
At close: 4:00 PM EST
kr0.01
<kr0.01(28.13%)
Day’s Range― - ―
52-Week Range<kr0.01 - kr0.12
Previous CloseN/A
Volume33.27M
Average Volume (3M)21.55M
Market Cap
kr1.06M
Enterprise Valuekr6.97M
Total Cash (Recent Filing)kr4.00K
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta-2.89
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,124,285,000
10 Day Avg. Volume10,784,979
30 Day Avg. Volume21,553,206
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.23
Price to Sales (P/S)8.19
P/FCF Ratio-0.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
QUIA FAQ
What was QuiaPEG Pharmaceuticals Holding AB’s price range in the past 12 months?
QuiaPEG Pharmaceuticals Holding AB lowest stock price was <kr0.01 and its highest was kr0.12 in the past 12 months.
What is QuiaPEG Pharmaceuticals Holding AB’s market cap?
QuiaPEG Pharmaceuticals Holding AB’s market cap is kr1.06M.
When is QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date?
QuiaPEG Pharmaceuticals Holding AB’s upcoming earnings report date is Aug 27, 2026 which is in 244 days.
How were QuiaPEG Pharmaceuticals Holding AB’s earnings last quarter?
QuiaPEG Pharmaceuticals Holding AB released its earnings results on Aug 28, 2025. The company reported -kr0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.003.
Is QuiaPEG Pharmaceuticals Holding AB overvalued?
According to Wall Street analysts QuiaPEG Pharmaceuticals Holding AB’s price is currently Overvalued.
Does QuiaPEG Pharmaceuticals Holding AB pay dividends?
QuiaPEG Pharmaceuticals Holding AB pays a Annually dividend of kr239.146 which represents an annual dividend yield of N/A. See more information on QuiaPEG Pharmaceuticals Holding AB dividends here
What is QuiaPEG Pharmaceuticals Holding AB’s EPS estimate?
QuiaPEG Pharmaceuticals Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does QuiaPEG Pharmaceuticals Holding AB have?
QuiaPEG Pharmaceuticals Holding AB has 2,124,285,000 shares outstanding.
What happened to QuiaPEG Pharmaceuticals Holding AB’s price movement after its last earnings report?
QuiaPEG Pharmaceuticals Holding AB reported an EPS of -kr0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.345%.
Which hedge fund is a major shareholder of QuiaPEG Pharmaceuticals Holding AB?
Currently, no hedge funds are holding shares in SE:QUIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
QuiaPEG Pharmaceuticals Holding AB
QuiaPEG Pharmaceuticals Holding AB (QUIA) is a biotechnology company focused on developing innovative drug delivery solutions utilizing its proprietary PEGylation technology. The company operates primarily in the pharmaceutical sector, enhancing the efficacy and safety profiles of therapeutic compounds through targeted delivery systems. QUIA’s core products include drug candidates designed to improve the pharmacokinetics of existing medications, particularly in the areas of oncology and autoimmune diseases.
Stayble Therapeutics AB
―
LIDDS AB
―
Lipigon Pharmaceuticals AB
―
Modus Therapeutics Holding AB
―
CombiGene AB
―